BONJELA TEETHING & MOUTH ULCER GEL choline salicylate 87 mg/g tube

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

choline salicylate, Quantity: 8.714 % w/w

Available from:

Reckitt Benckiser Pty Ltd

INN (International Name):

choline salicylate

Pharmaceutical form:

Gel

Composition:

Excipient Ingredients: ethanol; saccharin sodium; Star anise oil; hypromellose; cetalkonium chloride; purified water; menthol; glycerol

Administration route:

Buccal

Units in package:

15 g (on or after 1 Oct 2023), 15 g (until 30 Sep 2023)

Prescription type:

(S2) Pharmacy Medicine, Not scheduled. Not considered by committee

Therapeutic indications:

Provides fast-acting, soothing relief from the pain and discomfort associated with infant teething disorders, mouth ulcers and sores, and new dentures.

Product summary:

Visual Identification: Almost colourless viscous gel; Container Type: Tube; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

1991-07-04